IPO Calendar
Lead Manager
- J P Morgan Chase (482)
- Goldman Sachs (458)
- Morgan Stanley (413)
- Bank of America Merrill Lynch (354)
- Citigroup (222)
- Jefferies (211)
- Credit Suisse (180)
- Barclays (150)
- Cowen and Company (145)
- Deutsche Bank (81)
- Piper Jaffray (70)
- Leerink Partners (69)
- Stifel (65)
- UBS Investment Bank (52)
- Evercore (51)
- RBC Capital (50)
- BMO Capital (49)
- Wells Fargo (45)
- William Blair (37)
- Raymond James (36)
More +
IPO - Pricing (21)
Citigroup
UnderWriters* | |||||||||||
Date | Company Name | Sector | Price ($) |
Size (M) |
1 | 2 | 3 | Rank | Turnover | Gain | |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 21 | Canaan Inc. | Capital-Goods | 9 | 10 | CITI | CRNS | 40.7% | -0.1% | |||
Nov 7 | Galera Therapeu | Health-Care | 12 | 5 | BAML | CITI | CS | 26.3% | 0% | ||
Nov 1 | Fangdd Network | Finance | 13 | 6 | MS | CITI | UBS | 13.8% | 0% | ||
Oct 17 | Innate Pharma S | Health-Care | 5.5 | 12 | CITI | EVCR | 6.6% | 10% | |||
Oct 17 | BellRing Brands | Consumer-Non-Durables | 14 | 34 | MS | CITI | JPM | 25.7% | 17.9% | ||
Sep 12 | SmileDirectClub | Health-Care | 23 | 58 | JPM | CITI | BAML | 81.6% | -24.9% | ||
Aug 1 | Dynatrace Holdi | Technology | 16 | 35 | GS | JPM | CITI | 0.3% | 3.1% | ||
Jul 26 | Vista Oil & Gas | Energy | 9.3 | 10 | CITI | CS | 25% | -1.6% | |||
Jul 18 | Mirum Pharmaceu | Health-Care | 15 | 5 | CITI | EVCR | GGNH | 29.5% | -11.9% | ||
Jun 28 | Karuna Therapeu | Health-Care | 16 | 5 | GS | CITI | WLFG | 48.8% | 25.1% | ||
Jun 13 | Fiverr Internat | NA | 21 | 5 | JPM | CITI | 416% | 90% | |||
May 23 | IDEAYA Bioscien | NA | 10 | 5 | JPM | CITI | JEFF | 34.4% | 11.9% | ||
May 17 | Fastly Inc. | NA | 16 | 11 | BAML | CS | CITI | 141.9% | 49.9% | ||
May 13 | Applied Therape | NA | 10 | 4 | CITI | COWN | UBS | 33.6% | -6% | ||
May 9 | Mayville Engine | NA | 17 | 6 | BARD | CITI | JEFF | 45% | -3.1% | ||
Apr 12 | JUMIA Technolog | NA | 14.5 | 13 | MS | CITI | RBC | 69.9% | 75.6% | ||
Apr 4 | Tradeweb Market | NA | 27 | 40 | JPM | CITI | GS | 81.6% | 32.6% | ||
Apr 4 | NGM Biopharmace | NA | 16 | 6 | GS | CITI | COWN | 29.9% | -8.1% | ||
Mar 20 | UP Fintech Hold | NA | 8 | 13 | CITI | DB | 168.6% | 36.5% | |||
Feb 8 | Harpoon Therape | NA | 14 | 5 | CITI | LRNK | 24.3% | -3.6% | |||
Jan 31 | New Fortress En | NA | 14 | 20 | MS | BRCL | CITI | 20.2% | -6.6% |
*
Lead manager or one of top three managers in an underwriting team.